Founded in 2018, Bohui Biotech began by licensing HITV cancer immunotherapy from Japanese physician Dr. Kenichiro Hasumi, committing itself to the development of immunotherapy and precision cancer medicine. The company has continually pushed the boundaries of innovation and has also actively invested in exosome research. Its plant-derived exosomes have received INCI (International Nomenclature Cosmetic Ingredient) certification, making Bohui Biotech the first company to earn recognition for plant-based exosomes.

After confirming the skincare benefits of lotus leaf exosomes, Bohui Biotech launched its skincare brand, EXOGAIA. The entire product line features a unique combination of dual exosomes derived from both plant and animal sources, including lotus leaf exosomes and sheep placenta exosomes. This fusion delivers the combined benefits of botanical and animal exosomes, creating a perfect skin feel and helping consumers defy the visible signs of aging.

Bohui Biotech is honored to be the first company to use dual exosomes as cosmetic ingredients. The company is actively expanding its marketing efforts into North America, Southeast Asia, and China, further broadening the potential applications of exosome technology.

Liang Qingying, the brand ambassador for EXOGAIA, CEO of five traditional Chinese medicine clinics, and a certified nutritionist, shared her experience with us. This was also her first time using skincare products infused with dual exosomes. To ensure the product's gentleness, safety, and effectiveness, she conducted extensive research and discovered numerous studies confirming the significant skincare benefits of dual exosomes.